IL113983A0 - Panatropic neurotrophic factors - Google Patents

Panatropic neurotrophic factors

Info

Publication number
IL113983A0
IL113983A0 IL11398395A IL11398395A IL113983A0 IL 113983 A0 IL113983 A0 IL 113983A0 IL 11398395 A IL11398395 A IL 11398395A IL 11398395 A IL11398395 A IL 11398395A IL 113983 A0 IL113983 A0 IL 113983A0
Authority
IL
Israel
Prior art keywords
neurotrophic factors
panatropic
pantropic
neurotrophic
factors
Prior art date
Application number
IL11398395A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22962278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL113983(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL113983A0 publication Critical patent/IL113983A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL11398395A 1994-06-03 1995-06-01 Panatropic neurotrophic factors IL113983A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25393794A 1994-06-03 1994-06-03

Publications (1)

Publication Number Publication Date
IL113983A0 true IL113983A0 (en) 1995-10-31

Family

ID=22962278

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11398395A IL113983A0 (en) 1994-06-03 1995-06-01 Panatropic neurotrophic factors

Country Status (17)

Country Link
US (6) US5728803A (fr)
EP (1) EP0763107B1 (fr)
JP (1) JPH10501138A (fr)
CN (1) CN1159439C (fr)
AT (1) ATE280825T1 (fr)
AU (1) AU695144B2 (fr)
BR (1) BR9508019B1 (fr)
CA (1) CA2191064C (fr)
DE (1) DE69533698T2 (fr)
ES (1) ES2231786T3 (fr)
FI (1) FI120237B (fr)
IL (1) IL113983A0 (fr)
MX (1) MX9605971A (fr)
NO (1) NO317938B1 (fr)
NZ (1) NZ287762A (fr)
PT (1) PT763107E (fr)
WO (1) WO1995033829A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728803A (en) * 1994-06-03 1998-03-17 Genentech, Inc. Pantropic neurotrophic factors
DE19637718A1 (de) 1996-04-01 1997-10-02 Boehringer Mannheim Gmbh Rekombinante inaktive Core-Streptavidin Mutanten
CZ300296B6 (cs) * 1996-11-15 2009-04-15 Genentech, Inc. Zpusob izolace rekombinantního lidského neurotrofinu, neurotrofinový prostredek a zpusob cištení neurotrofinu
US6391571B1 (en) 1997-04-01 2002-05-21 Roche Diagnostics Gmbh Recombinant inactive avidin mutants
US6365373B2 (en) 1997-04-25 2002-04-02 Genentech, Inc. Nucleic acids encoding NGF variants
AU7154698A (en) * 1997-04-25 1998-11-24 Genentech Inc. Ngf variants
US7452863B1 (en) 1997-04-29 2008-11-18 Genentech, Inc. NGF variants
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6663899B2 (en) 1997-06-13 2003-12-16 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6652864B1 (en) * 1998-12-21 2003-11-25 Asilomar Pharmaceuticals, Inc. Compounds for intracellular delivery of therapeutic moieties to nerve cells
US20040120891A1 (en) * 1998-12-21 2004-06-24 Craig Hill Compounds for intracellular delivery of therapeutic moieties to nerve cells
GB0024550D0 (fr) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
EP2340849A1 (fr) * 2001-05-30 2011-07-06 Genentech, Inc. Anticorps anti-NGF pour le traitement de diverses maladies
WO2004016167A1 (fr) * 2002-08-16 2004-02-26 The General Hospital Corporation Imagerie fonctionnelle non invasive de l'activation du systeme nerveux peripherique chez les humains et les animaux
EP1891966B1 (fr) * 2002-12-20 2012-02-15 H. Lundbeck A/S Modulation de l'activité des neurotrophines; methode de criblage
WO2006072005A2 (fr) * 2004-12-30 2006-07-06 The Johns Hopkins University Techniques hautement efficaces de survie/proliferation de cellules souches embryonnaires humaines et de survie d'embryons humains en culture
DK2120997T3 (en) * 2006-12-21 2017-05-08 H Lundbeck As MODULATION OF PRO-NEUROTROPHIN ACTIVITY
WO2009062149A1 (fr) * 2007-11-08 2009-05-14 Creighton University Procédés pour conserver les neurones de l'oreille interne
US8447409B2 (en) * 2008-10-15 2013-05-21 Cochlear Limited Electroneural interface for a medical implant
US8259461B2 (en) * 2008-11-25 2012-09-04 Micron Technology, Inc. Apparatus for bypassing faulty connections
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
US9539324B2 (en) 2010-12-01 2017-01-10 Alderbio Holdings, Llc Methods of preventing inflammation and treating pain using anti-NGF compositions
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US9078878B2 (en) 2010-12-01 2015-07-14 Alderbio Holdings Llc Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
US9067988B2 (en) 2010-12-01 2015-06-30 Alderbio Holdings Llc Methods of preventing or treating pain using anti-NGF antibodies
CN103619879A (zh) 2010-12-01 2014-03-05 奥尔德生物控股有限责任公司 抗ngf组合物及其用途
WO2017157326A1 (fr) 2016-03-18 2017-09-21 舒泰神（北京）生物制药股份有限公司 Facteur de croissance du tissu nerveux muté
CN107286233B (zh) * 2016-04-13 2020-11-06 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN110183536B (zh) * 2018-02-22 2021-01-15 中国科学院遗传与发育生物学研究所 一种复合支架材料及其应用
EP3823674A4 (fr) 2018-07-18 2022-12-28 Manzanita Pharmaceuticals, Inc. Conjugués pour administrer un agent anticancéreux à des cellules nerveuses, méthodes d'utilisation et leurs procédés de fabrication
CN110812532A (zh) * 2019-08-20 2020-02-21 中山大学 一种靶向促进皮质脊髓束连接以修复脊髓损伤的组织工程支架的构建方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5349055A (en) * 1992-03-06 1994-09-20 Persson Hakan B Nerve growth factor having altered receptor binding specificities
US5488099A (en) * 1992-03-06 1996-01-30 Persson, Deceased; Hakan B. Multifunctional chimeric neurotrophic factors
EP0644937A4 (en) * 1992-06-12 1995-05-03 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on neurotrophin-4 expression.
US5753225A (en) * 1993-12-03 1998-05-19 The Regents Of The University Of California Antibodies that mimic actions of neurotrophins
EP0749980A4 (fr) * 1993-12-29 1999-09-29 Sumitomo Pharma Nouveau facteur neurotrophique ciliaire humain
US7144983B1 (en) * 1997-02-03 2006-12-05 Genentech, Inc. Pantropic neurotrophic factors
US5728803A (en) * 1994-06-03 1998-03-17 Genentech, Inc. Pantropic neurotrophic factors

Also Published As

Publication number Publication date
JPH10501138A (ja) 1998-02-03
DE69533698T2 (de) 2006-02-09
NO965123L (no) 1997-02-03
DE69533698D1 (de) 2004-12-02
AU2659295A (en) 1996-01-04
NZ287762A (en) 1999-01-28
EP0763107B1 (fr) 2004-10-27
MX9605971A (es) 1997-12-31
FI964833A0 (fi) 1996-12-03
CA2191064A1 (fr) 1995-12-14
US5981480A (en) 1999-11-09
ATE280825T1 (de) 2004-11-15
CN1153528A (zh) 1997-07-02
EP0763107A1 (fr) 1997-03-19
US7528233B2 (en) 2009-05-05
CN1159439C (zh) 2004-07-28
FI964833A (fi) 1996-12-03
ES2231786T3 (es) 2005-05-16
NO317938B1 (no) 2005-01-10
US5728803A (en) 1998-03-17
US6333310B1 (en) 2001-12-25
BR9508019B1 (pt) 2012-06-12
FI120237B (fi) 2009-08-14
US20060270838A1 (en) 2006-11-30
BR9508019A (pt) 1997-09-09
US7935671B2 (en) 2011-05-03
CA2191064C (fr) 2009-11-03
US6503728B1 (en) 2003-01-07
NO965123D0 (no) 1996-12-02
WO1995033829A1 (fr) 1995-12-14
PT763107E (pt) 2005-02-28
US20100184656A1 (en) 2010-07-22
AU695144B2 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
IL113983A0 (en) Panatropic neurotrophic factors
DE69331484D1 (de) N-Acetylglucosaminyl-Transferase, dafür kodierendes Gen, entsprechende Vektoren und transformierte Wirte und Herstellungsverfahren dafür
DE69421100D1 (de) Aufbereitung von schweren endprodukten des fischer-tropsch-verfahrens
AU8154694A (en) Methods of increasing TGF-13 in the brain, inhibiting Alzeheimers disease and inhibiting B-amyloid peptide mediated neurotoxicity.
WO1996017072A3 (fr) Vecteurs d'alphavirus de recombinaison
CA2258895A1 (fr) Utilisation du topiramate ou de ses derives pour la preparation d'un medicament traitant les troubles bipolaires
MY115977A (en) Synthetic excitatory amino acids
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
EP0820467A4 (fr) Procedes de traitement de troubles oculaires
HK1024622A1 (en) Il 12 for the gene therapy of tumours
EP0647134A4 (fr) Procedes et compositions utilises pour traiter la depression et d'autres affections avec de la sibutramine (-) optiquement pure.
ZA941281B (en) Hyper-sensitivity related gene.
GB2367061A (en) Peptides
PL334012A1 (en) Novel method of treating the arthritis
WO2000021513A3 (fr) Procedes pour traiter la sclerose en plaques
WO2002004677A3 (fr) Procede destine au diagnostic et au traitement de troubles mentaux
BR9609631A (pt) Isocromanos 1,6-dissubstituídos para tratamento de cefaléias de enxaqueca
IL109280A0 (en) Neurotrophins for treatment of depression
DE69422928D1 (de) Modifizierte maxadilan-protein, dessen herstellung und verwendung, und dem protein kodierende dns
AU5997096A (en) Cocoa flavour precursor peptides, dna encoding them, process es for producing the peptides, and their use for generating cocoa flavour
EP0572139A3 (fr) Procédé et produit enzymatique de protéine.
EP0613155A3 (fr) Fil isolé résistant à la chaleur et méthode de fabrication.
EP0856580A4 (fr) Conglutinine recombinee et son procede de production
EP0591784A3 (en) Use of grafted polyorganosiloxane products for the finishing of leather
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired